FDA Inspection 1075013 — CSL Plasma Inc.
The FDA completed an inspection of CSL Plasma Inc. on Dec 14, 2018 in Akron, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 14, 2018
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Akron, OH (United States)